These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8600607)

  • 1. A comparison of the metabolic effects of captopril and atenolol on glucose, insulin and lipoproteins in patients with mild-to-moderate essential hypertension.
    Maritz FJ; Weich HF; Schoeman HS
    S Afr Med J; 1995 Dec; 85(12 Pt 2):1342-5. PubMed ID: 8600607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
    Pollare T; Lithell H; Berne C
    N Engl J Med; 1989 Sep; 321(13):868-73. PubMed ID: 2671740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
    Thulin T; Lehtonen A; Dahlöf C; Nilsson-Ehle P; Engqvist L; Lagerstedt C; Berglund E
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
    Witchitz S; Provendier O; Arsenescu I
    Presse Med; 1996 Dec; 25(40):2013-6. PubMed ID: 9082374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):129-34. PubMed ID: 2655902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE; Johansson J; Berne C; Lithell H
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters.
    Lithell HO; Pollare T; Berne C
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S46-52. PubMed ID: 1694931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Shichiri M; Sunaga T; Mashiba H; Tanaka N; Nonaka K; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):366-70. PubMed ID: 7582390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term metabolic effects of antihypertensive drugs.
    Lind L; Pollare T; Berne C; Lithell H
    Am Heart J; 1994 Dec; 128(6 Pt 1):1177-83. PubMed ID: 7985599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.
    Hauf-Zachariou U; Widmann L; Zülsdorf B; Hennig M; Lang PD
    Eur J Clin Pharmacol; 1993; 45(2):95-100. PubMed ID: 8223847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
    Fagerberg B; Berglund A; Holme E; Wilhelmsen L; Elmfeldt D
    J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
    Pollare T; Lithell H; Mörlin C; Präntare H; Hvarfner A; Ljunghall S
    J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T; Westlie L; Daae L
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.